Exenatide and Renal Outcomes in Patients with Type 2 Diabetes and Diabetic Kidney Disease.

CONCLUSION: Exenatide plus insulin glargine treatment for 24 weeks resulted in a reduction of albuminuria in T2DM patients with DKD. PMID: 32966971 [PubMed - as supplied by publisher]
Source: American Journal of Nephrology - Category: Urology & Nephrology Authors: Tags: Am J Nephrol Source Type: research